Compare BKR & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKR | CAH |
|---|---|---|
| Founded | 2016 | 1979 |
| Country | United States | United States |
| Employees | 64000 | N/A |
| Industry | Metal Fabrications | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.5B | 52.0B |
| IPO Year | 2017 | 1994 |
| Metric | BKR | CAH |
|---|---|---|
| Price | $63.28 | $222.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 11 |
| Target Price | $58.50 | ★ $229.09 |
| AVG Volume (30 Days) | ★ 9.1M | 1.5M |
| Earning Date | 04-27-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.45% | 0.91% |
| EPS Growth | 56.02 | ★ 86.96 |
| EPS | ★ 2.98 | 1.88 |
| Revenue | $27,733,000,000.00 | ★ $222,578,000,000.00 |
| Revenue This Year | $1.98 | $17.34 |
| Revenue Next Year | $6.10 | $8.95 |
| P/E Ratio | ★ $21.39 | $120.24 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $33.62 | $120.72 |
| 52 Week High | $64.26 | $230.20 |
| Indicator | BKR | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 71.01 | 54.08 |
| Support Level | $44.09 | $206.07 |
| Resistance Level | N/A | $230.20 |
| Average True Range (ATR) | 1.54 | 6.76 |
| MACD | 0.07 | -0.24 |
| Stochastic Oscillator | 85.63 | 64.69 |
Following a 2022 reorganization, Baker Hughes operates in two segments: oilfield services and equipment, and industrial and energy technology. The firm's oilfield services and equipment segment is one of the Big Three oilfield-services players, along with SLB and Halliburton, and mostly supplies to hydrocarbon developers and producers, including national oil companies, major integrated firms, and independents. Markets outside of North America buy roughly three-fourths of the segment's offerings. Baker Hughes' industrial and energy technology segment manufactures and sells turbines, compressors, pumps, valves, and related testing and monitoring services for various energy and industrial applications.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.